DoH Policies screened during the period: 1 April 2022 -30 June 2022
Date published:
In fulfilling its obligations under Section 75 the Department is required to equality screen all of its policies and services under consideration to determine whether they should be subject to a full equality impact.
Documents
- NICE Clinical Guideline NG197 - Shared decision making (partially updates and replaces CG138)
- NICE Clinical Guideline NG211 - Rehabilitation after traumatic injury
- NICE Technology Appraisal TA779 - Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency
- NICE Technology Appraisal TA780 - Nivolumab with ipilimumab for untreated advanced renal cell carcinoma (review of TA581)
- NICE Technology Appraisal TA781 - Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer
- NICE Technology Appraisal TA783 - Daratumumab monotherapy for treating relapsed and refractory multiple myeloma (review of TA510)
- NICE Technology Appraisal TA784 - Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer (review of TA528)
- NICE Technology Appraisal TA786 - Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies
- NICE Technology Appraisal TA788 - Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy
- NICE Technology Appraisal TA789 - Tepotinib for treating advanced non-small-cell lung cancer with MET gene alterations
- NICE Technology Appraisal TA791 - Romosozumab for treating severe osteoporosis
- NICE Technology Appraisal TA792 - Filgotinib for treating moderately to severely active ulcerative colitis
- SSPG - Provision of Trauma-Informed Personal Development and Resilience Programme, Counselling and Information Services
- Regulations for Area Integrated Partnership Boards (AIPBs)
- Review of General Surgery
- Making of a Statutory Rule of the Public Health Act (Northern Ireland) 1967, whereby Schedule 1 to the Act (Notifiable Diseases) shall be amended by the insertion of monkeypox
- Reshaping Stroke Care: Saving Lives, Reducing Disability – Stroke Action Plan